These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 4573132)

  • 21. Frozen blood in transplant recipients to avoid hepatitis and-or HL-A sensitization.
    Huggins CE; Russell PS; Winn HJ; Fuller TC; Beck CH
    Transplant Proc; 1972 Dec; 4(4):575-6. PubMed ID: 4630297
    [No Abstract]   [Full Text] [Related]  

  • 22. [Viral hepatitis in chronic hemodialysis and kidney transplantation].
    Degos F
    Gastroenterol Clin Biol; 1983 Nov; 7(11):923-9. PubMed ID: 6317506
    [No Abstract]   [Full Text] [Related]  

  • 23. Renal transplantation in patients with Australia antigenemia.
    Reed W; Lucas ZJ; Kempson R; Cohn R
    Transplant Proc; 1971 Mar; 3(1):343-6. PubMed ID: 4937902
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical aspects on an outbreak of hepatitis among personnel in hemodialysis units.
    Ringertz O; Nyström B; Ström J
    Scand J Infect Dis; 1969 May; 1(1):51-6. PubMed ID: 4106501
    [No Abstract]   [Full Text] [Related]  

  • 25. Combined report on regular dialysis and transplantation in Europe, VII, 1976.
    Jacobs C; Brunner FP; Chantler C; Donckerwolcke RA; Gurland HJ; Hathway RA; Selwood NH; Wing AJ
    Proc Eur Dial Transplant Assoc; 1977; 14():3-69. PubMed ID: 341130
    [No Abstract]   [Full Text] [Related]  

  • 26. Control of serum hepatitis in a dialysis unit.
    Bosch E; Kolk-Vegter AJ
    Neth J Med; 1973; 16(4):200-11. PubMed ID: 4750040
    [No Abstract]   [Full Text] [Related]  

  • 27. [Infections with hepatitis B virus in hemodialysis units of Wielkopolska].
    Grzegorzewska AE; Kurzawska-Firlej D; Swiderski A; de Mezer-Dambek M; Frankiewicz D; Zaremba-Drobnik D; Banachowicz W; Dumanowska-Zmuda A; Ratajewski W; Niepolski L; Krawczyk R; Sobolewski J; Pulchny J; Molenda J; Wojciechowski J; Mikstacki Z; Zachwieja J
    Przegl Epidemiol; 2008; 62(1):29-37. PubMed ID: 18536222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long incubation hepatitis and tattooing.
    Thomas E; Kearney BJ; Beare JH
    Med J Aust; 1973 Apr; 1(15):739-41. PubMed ID: 4707369
    [No Abstract]   [Full Text] [Related]  

  • 29. Combined report on regular dialysis and transplantation in Europe, II, 1971.
    Brunner FP; Gurland HJ; Härlen H; Schärer K; Parsons FM
    Proc Eur Dial Transplant Assoc; 1972; 9():3-34. PubMed ID: 4589763
    [No Abstract]   [Full Text] [Related]  

  • 30. [Importance of checking serum markers of hepatitis B in Dialysis Centers: study conducted on patients, family "contacts" and personnel of 3 hemodialysis centers].
    Di Landro D; Pornaro E; Neumair F; Gasparotto ML; Bertoli M; Cerutti M; Naso A; Perin N; Puma G; Romagnoli GF
    Minerva Nefrol; 1982; 29(1):43-7. PubMed ID: 7099483
    [No Abstract]   [Full Text] [Related]  

  • 31. Hepatitis and the treatment of chronic renal failure.
    Lancet; 1972 Jul; 2(7768):122. PubMed ID: 4113899
    [No Abstract]   [Full Text] [Related]  

  • 32. Hepatitis B and renal transplantation: dangling the sword of damocles?
    Ryan MJ
    Am J Gastroenterol; 1992 Dec; 87(12):1882-3. PubMed ID: 1449162
    [No Abstract]   [Full Text] [Related]  

  • 33. Statement on hepatitis B antigen carriers.
    Hospitals; 1974 Nov; 48(21):95, 98. PubMed ID: 4415883
    [No Abstract]   [Full Text] [Related]  

  • 34. Viral hepatitis and the dental treatment of renal dialysis and kidney transplant patients.
    Uthman AA
    J Oral Med; 1975; 30(3):70-2. PubMed ID: 1095702
    [No Abstract]   [Full Text] [Related]  

  • 35. Hepatitis B virus markers among family contacts and medical personnel of 239 hemodialysis patients.
    Gahl GM; Vogl E; Kraft D; Hess G; Arnold W
    Clin Nephrol; 1980 Jul; 14(1):8-12. PubMed ID: 7408256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergence of hepatitis B infection despite antibodies to hepatitis B surface antigen: a new nosocomial risk in patients with end-stage renal disease.
    Moal V; Vacher-Coponat H; Botelho E; Berland Y; Colson P; Tamalet C; Henry M
    Transplantation; 2006 May; 81(9):1358-9. PubMed ID: 16699469
    [No Abstract]   [Full Text] [Related]  

  • 37. National surveillance of dialysis associated diseases in the United States, 1992.
    Tokars JI; Alter MJ; Favero MS; Moyer LA; Miller E; Bland LA
    ASAIO J; 1994; 40(4):1020-31. PubMed ID: 7858322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Serum hepatitis in the hemodialysis and kidney transplantation centers].
    Lopatkin NA; Kuchinskiĭ IN; Iarmagomedov AA; Danilkov AP
    Sov Med; 1973 Oct; 36(10):112-6. PubMed ID: 4596822
    [No Abstract]   [Full Text] [Related]  

  • 39. [Recent advances in the study of viral hepatitis].
    Couroucé AM; Trépo C; Jungers P
    Nouv Presse Med; 1979 May; 8(21):1731-4. PubMed ID: 377218
    [No Abstract]   [Full Text] [Related]  

  • 40. Hemodialysis-associated hepatitis. An outbreak among hospital personnel.
    Hennekens CH
    JAMA; 1973 Jul; 225(4):407-8. PubMed ID: 4741014
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.